Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

The Truth About Implants

September 3rd 2019

Before getting breast implants, women should know about a cancer (breast implant-associated anaplastic large cell lymphoma) and an autoimmune syndrome associated with them.

Patients Need Facts About Rare Cancers, Like Lymphoma Associated With Breast Implants

August 29th 2019

Knowledge is essential for any patient facing cancer, and this issue provides the facts not only about breast implant-associated anaplastic large cell lymphoma but also other rare cancer types or mutations.

Medicare Coverage of CAR-T Cell Therapy Opens Patient Access to Life-Saving Treatment

August 17th 2019

Following its announcement of covering chimeric antigen receptor-T cell therapy nationwide, the Centers for Medicare and Medicaid Services has now made this highly-priced, but life-saving, treatment available to many who would not otherwise have access to it at their cancer centers.

Gluteal Implants May Be Associated with Cancer

August 6th 2019

The first gluteal implant case has raised concern for risk of anaplastic large cell lymphoma in more than just textured breast implants.

A Three-Time Cancer Survivor Finds a 'Ray of Light' and Opens Up About Her First Diagnosis

August 6th 2019

Three-time cancer survivor and “Pink Hulk” one-woman show writer and performer, Valerie David, recalls the day she learned she had non-Hodgkin lymphoma.

Breast Implant-Associated Cancer: What You Should Know

August 1st 2019

A lymphoma expert discusses implant removal, reconstruction and the signs of anaplastic large cell lymphoma.

FDA Asks Allergan to Voluntarily Recall Breast Implants to Protect Against Rare Cancer

July 24th 2019

The Food and Drug Administration has requested that the manufacturer voluntarily recall certain breast implants and tissue expanders from the market to protect women from risks such as breast implant-associated anaplastic large cell lymphoma.

FDA Approves Biosimilar Ruxience: Here's What You Need to Know

July 24th 2019

With the Food and Drug Administration’s approval of Ruxience, a biosimilar to Rituxan, patients with certain types of non-Hodgkin lymphoma and chronic lymphocytic leukemia may have improved access to a more affordable treatment option.

Looking Into the Future with the #AgeChallenge

July 23rd 2019

How an app gives a glimpse into the future for many patients with cancer and survivors who fear they won't make it to old age.

Innovative Therapy Given Fast Track Designation for Diffuse Large B-Cell Lymphoma

July 9th 2019

The Food and Drug Administration granted CLR 131, a targeted, molecular radiotherapy, a fast track designation.

Adcetris Is a 'Good Treatment' for Patients With Advanced Hodgkin Lymphoma

July 4th 2019

A lymphoma expert discusses the side effect profile and follow-up data from the ECHELON-1 clinical trial.

Breast Implant-Associated Lymphoma: Do I Need to be Concerned?

June 27th 2019

Women who undergo a mastectomy have many options and concerns to consider when undergoing breast reconstruction. My choice was simple: I wanted to look as natural as possible, but I have since learned that I have textured implants.

The Force Is Strong With Cancer Survivors: Joining My Rebel Alliance

June 21st 2019

When I was diagnosed with Hodgkin's lymphoma, I envisioned myself in a galaxy far, far away. Just like any well-trained Jedi, I fought back when insurance denied my claim for doctor-recommended treatment.

Three Things to Avoid When Trying to Feel Normal Again After Cancer

June 10th 2019

Here are three things I learned to avoid when recovering from cancer treatment.

FDA Grants Polivy Accelerated Approval for DLBCL

June 10th 2019

The FDA has granted an accelerated approval to Polivy for use in combination with bendamustine and Rituxan for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma who have received at least two prior therapies.

'Here Comes the Sun' and Innovation

June 3rd 2019

Having hope in the now is really faith in the future.

FDA Approves Revlimid/Rituxan Combo for Indolent Non-Hodgkin Lymphoma

May 28th 2019

The Food and Drug Administration has approved the combination regimen of Revlimid plus Rituxan for use in patients with previously-treated follicular lymphoma and marginal zone lymphoma.

FDA Approves Jakafi for the Treatment of Patients with Acute Graft-Versus-Host Disease

May 24th 2019

The FDA has approved Jakafi, the first and only treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients aged 12 years and older.

Friday Frontline: May 24, 2019

May 24th 2019

From World Blood Cancer Day to today’s top performers fundraising for lifesaving research, here’s what’s making headlines in the cancer space this week.

Firsthand Experience With CAR T-Cell Therapy

May 23rd 2019

In this episode, we spoke with a rare lymphoma survivor on how chimeric antigen receptor T-cell therapy saved her life.

Speaking Out About Breast Implant-Associated Cancer

May 9th 2019

In this episode of CURE® Talks Cancer, we spoke with an advocate who is raising awareness around the recent controversy surrounding a certain type of breast implant that is causing a rare type of lymphoma.

Survey Shows Split Between Blood Cancer Detection: Symptom Evaluation vs. Incidental Finding

April 30th 2019

Only half of patients reported their blood cancer was detected while visiting a doctor after experiencing symptoms versus detection during a routine medical test or exam or while under the care of a doctor for another health condition.

Running to Raise Money and Awareness for Cancer

April 26th 2019

Extraordinary Healer® Award finalist Angela Hammack, B.S.N., RN, OCN, discussed how she began running marathons to raise awareness – and $100,000 – for cancer.

CURE's Top 5 Stories: March 2019

April 1st 2019

Here are the top 5 CURE stories for March 2019.

Cats Didn't Give Me Cancer

March 22nd 2019

How being treated for an allergy to cats and persistence finally led to my diagnoses of Hodgkin's lymphoma.

Parent Caregivers Face Decreased Job Productivity

March 5th 2019

Productivity loss among parent caregivers associated with poor health-related quality of life in pediatric advanced stage Hodgkin lymphoma.

How Cancer Made Me Feel Like I Was Caught in My Underwear for the World to See

March 5th 2019

In order to help others, this survivor and author must "bare all" to get his message out.

Reduced Treatment Proves Safer and Just as Effective in Younger Patients With Diffuse Large B-Cell Lymphoma

March 3rd 2019

Treating younger patients with low-risk diffuse large B-cell lymphoma (DLBCL) with two fewer front-line cycles of standard treatment greatly reduced toxicity without sacrificing effi­cacy.

FDA Grants Priority Review to Revlimid Plus Rituxan for Indolent Non-Hodgkin Lymphoma

February 27th 2019

The Food and Drug Administration granted a priority review to Revlimid (lenalidomide) plus Rituxan (rituximab) for the treatment of patients with previously treated follicular lymphoma and marginal zone lymphoma.

FDA Grants Priority Review to Antibody Drug Conjugate for Diffuse Large B-Cell Lymphoma

February 19th 2019

The Food and Drug Administration granted a priority review to polatuzumab vedotin in combination with bendamustine plus Rituxan (rituximab) for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).